What You Should Know:
– Accenture and Salesforce are investing in the development of Salesforce Life Sciences Cloud, focusing on innovation, assets, and accelerators powered by data and artificial intelligence (AI) to help life sciences companies create sustainable value and drive growth.
– Building on their generative AI collaboration, Accenture and Salesforce will leverage their joint generative AI acceleration hub to develop new solutions and use cases for Salesforce Life Sciences Cloud.
Salesforce Data Cloud and Einstein AI
According to Accenture Research, 58% of life sciences companies consider the accelerated adoption of data and analytics capabilities as a top investment priority. As part of the collaboration, both will use Salesforce Data Cloud and Einstein AI, Salesforce’s AI technology, to enhance productivity and transform healthcare professional and patient experiences.
The patient services Health Cloud assessment framework generates insights and a value case for Salesforce Life Sciences Cloud. The pharmaceutical Data Cloud and Einstein AI accelerator leverages generative AI to provide a holistic view of provider and patient data and suggest the most important messages for patient interactions.
Future Development
Accenture will continue to develop complementary tools and methodologies to help clients test and pilot the new capabilities of Salesforce Life Sciences Cloud.
